Acquired Factor VIII deficiency: Rapid and complete remission after immunosuppressive therapy with high dose cyclophosphamide and Rituximab.

被引：0
|
作者：
Tamponi, G [1 ]
Schinco, P [1 ]
Borchiellini, A [1 ]
Valpreda, A [1 ]
Pollio, B [1 ]
Boccadoro, M [1 ]
机构：
[1] Univ Turin, I-10124 Turin, Italy
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3882
引用
收藏
页码：101B / 101B
页数：1
相关论文
共 50 条
  • [41] COMPLETE RESPONSE AFTER HIGH-DOSE THERAPY WITH AUTOLOGOUS STEM CELL SUPPORT IS THE ONLY IMPORTANT PREDICTIVE FACTOR FOR SURVIVAL
    Lee, B.
    Shin, S. H.
    Min, C. K.
    Yhim, H. Y.
    Kwak, J. Y.
    Kim, J. A.
    HAEMATOLOGICA, 2012, 97 : 408 - 408
  • [42] ACQUIRED FIBRINOGEN AND FACTOR-VII DEFICIENCY DURING AND AFTER IMMUNOSUPPRESSIVE THERAPY WITH ANTITHYMOCYTE GLOBULIN (ATG) AND HIGH-DOSES OF 6-METHYLPREDNISOLONE (MP) AGAINST SEVERE APLASTIC-ANEMIA (SAA)
    FISCHER, M
    DUDCZAK, R
    GEISSLER, K
    HINTERBERGER, W
    KORNINGER, C
    LECHNER, K
    NEUMANN, E
    NIESSNER, H
    PABINGER, I
    SCHWARZINGER, I
    ACTA MEDICA AUSTRIACA, 1985, 12 : 15 - 15
  • [43] Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy
    Bregni, M
    Siena, S
    DiNicola, M
    Dodero, A
    Peccatori, F
    Ravagnani, F
    Danesini, G
    Laffranchi, A
    Bonadonna, G
    Gianni, AM
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (02) : 628 - 635
  • [44] COMPLETE REMISSION IN ACUTE MYELOID-LEUKEMIA AFTER TREATMENT WITH RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR AND HIGH-DOSE INTRAVENOUS METHYLPREDNISOLONE
    SUGAWARA, T
    SATO, A
    SHISHIDO, T
    OKUDA, M
    KAMEOKA, J
    MEGURO, K
    ENDO, K
    YOSHINAGA, K
    BRITISH JOURNAL OF HAEMATOLOGY, 1991, 77 (04) : 561 - 562
  • [45] Combined therapeutic modality with rituximab, fludarabin and cyclophosphamide followed by high dose therapy with autologous stem cell transplantation (ASCT) leads to excellent response rate and high probability of molecular remission in chronic lymphocytic leukemia (CLL) patients.
    Trneny, M
    Salkova, J
    Karban, J
    Cerny, J
    Michalova, K
    Slavickova, A
    Stritesky, J
    Pytlik, R
    Straub, J
    Koleskova, E
    BLOOD, 2002, 100 (11) : 804A - 804A
  • [46] The role of high-dose cytarabine as consolidation therapy before allogeneic hematopoietic cell transplantation for acute myeloid leukaemia without core-binding factor in the first complete remission
    Lee, Yoo Jin
    Sohn, Sang Kyun
    Moon, Joon Ho
    Kim, Hyeoung-Joon
    Ahn, Jae Sook
    Ahn, Seo-Yeon
    Do, Young Rok
    Lee, Ji Hyun
    BONE MARROW TRANSPLANTATION, 2018, 53 : 191 - 192
  • [47] High-dose consolidation chemotherapy with autologous transplantation after intensive sequential induction therapy improves complete remission rate in patients with poor prognosis non-Hodgkin lymphomas
    Papajik, T
    Raida, L
    Faber, E
    Vondráková, J
    Urbanová, R
    Pikalová, Z
    Vlachová, S
    Jarosová, M
    Kajaba, V
    Zapletalová, J
    Indrák, K
    BONE MARROW TRANSPLANTATION, 2004, 33 : S352 - S352
  • [48] A recent update of 3 consecutive prospective trials with high-dose therapy and autograft, without or with rituximab, as primary treatment for advanced-stage follicular lymphoma shows a sizeable group of patients surviving in continuous complete remission
    Tarella, C.
    Ladetto, M.
    Benedetti, F.
    Vitolo, U.
    Pulsoni, A.
    Patti, C.
    Callea, V.
    Rambaldi, A.
    Piccin, A.
    Devizzi, L.
    Musso, M.
    Iannitto, E.
    Spedini, P.
    Liberati, A. M.
    Ciceri, F.
    Gallamini, A.
    Rodeghiero, F.
    Gini, G.
    De Crescenzo, A.
    Di Raimondo, F.
    Levis, A.
    Chisesi, T.
    Petrone, T.
    Scalabrini, D. Rota
    Rossi, G.
    Carella, A. M.
    Parvis, G.
    Majolino, I.
    Passera, R.
    Ruella, M.
    Pileri, A.
    Gianni, A. M.
    Corradini, P.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S42 - S43
  • [49] High-dose therapy and autologous peripheral blood stem cells transplantation followed by a very low reduced intensity regimen with fludarabine plus cyclophosphamide and allograft improve complete remission rate in de novo multiple myeloma patients
    Martino, Massimo
    Console, Giuseppe
    Irrera, Giuseppe
    Pratico, Giulia
    Stelitano, Caterina
    Callea, Vincenzo
    Morabito, Fortunato
    Quartarone, Eugenia
    Musolino, Caterina
    Piro, Eugenio
    Brugiatelli, Maura
    Iacopino, Pasquale
    AMERICAN JOURNAL OF HEMATOLOGY, 2006, 81 (12) : 973 - 978
  • [50] HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE (BCNU), AND ETOPOSIDE (VP16-213) WITH OR WITHOUT CISPLATIN (CBV+/-P) AND AUTOLOGOUS TRANSPLANTATION FOR PATIENTS WITH HODGKINS-DISEASE WHO FAIL TO ENTER A COMPLETE REMISSION AFTER COMBINATION CHEMOTHERAPY
    REECE, DE
    BARNETT, MJ
    SHEPHERD, JD
    HOGGE, DE
    KLASA, RJ
    NANTEL, SH
    SUTHERLAND, HJ
    KLINGEMANN, HG
    FAIREY, RN
    VOSS, NJ
    CONNORS, JM
    OREILLY, SE
    SPINELLI, JJ
    PHILLIPS, GL
    BLOOD, 1995, 86 (02) : 451 - 456
12345